Alan Marchbanks, PA
Physician Assistant · Glendale, AZNPI 1992745103
Payments from drug & device makers
Across 242 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$589
- AstraZeneca$483
- Abbott$460
- Boehringer Ingelheim$376
- Bayer$313
- Sanofi-aventis U.S. LLC$210
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,318100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $589 |
| AstraZeneca | 26 | $483 |
| Abbott | 32 | $460 |
| Boehringer Ingelheim | 18 | $376 |
| Bayer | 20 | $313 |
| Sanofi-aventis U.S. LLC | 12 | $210 |
| Amgen | 18 | $207 |
| GSK | 9 | $185 |
| Gilead | 8 | $175 |
| Nestle Healthcare Nutrition Inc. | 9 | $159 |
| Sumitomo Pharma America, Inc. | 5 | $146 |
| Aimmune Therapeutics, Inc. | 5 | $105 |
| Lilly USA, LLC | 6 | $91 |
| Novo Nordisk | 6 | $88 |
| Astellas Pharma US Inc | 3 | $75 |
| Lucid Diagnostics Inc. | 3 | $73 |
| Dexcom, Inc. | 3 | $69 |
| Boston Scientific | 2 | $63 |
| Pfizer | 4 | $60 |
| Johnson & Johnson | 2 | $46 |
| Hologic Sales And Service, LLC | 2 | $42 |
| Intuitive Surgical | 2 | $37 |
| Novartis | 2 | $37 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Nevro Corp. | 1 | $28 |
| Corcept Therapeutics | 1 | $26 |
| Amarin Pharma, Inc. | 2 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Abiomed | 1 | $19 |
| Merck | 1 | $19 |
| Optinose US, Inc. | 1 | $14 |
How this compares
$4,318 in reported general payments places this provider in the 90th percentile of 2,888 physician assistant providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 70 | $121,708 |
| FarxigaDapagliflozin Propanediol | 46 | $55,965 |
| JardianceEmpagliflozin | 32 | $54,618 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $45,939 |
| EliquisApixaban | 38 | $44,152 |
| OzempicSemaglutide | 12 | $24,601 |
| JanuviaSitagliptin Phosphate | 14 | $22,560 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $15,657 |
| XareltoRivaroxaban | 35 | $12,554 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $6,526 |
| Atorvastatin Calcium | 438 | $3,792 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 127 | $3,387 |
| Omeprazole | 159 | $2,657 |
| Gabapentin | 94 | $2,095 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $1,934 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $91 | $121,70870 claims |
| AstraZenecaFarxiga | $483 | $55,96546 claims |
| Boehringer IngelheimJardiance | $376 | $54,61832 claims |
| GSKTrelegy Ellipta | $185 | $45,93930 claims |
| PfizerEliquis | $60 | $44,15238 claims |
| Novo NordiskOzempic | $88 | $24,60112 claims |
| MerckJanuvia | $19 | $22,56014 claims |
| Johnson & JohnsonXarelto | $46 | $12,55435 claims |
| Sanofi-aventis U.S. LLCLantus | $210 | $1,87013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Glendale
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Kayla BrattonGlendale$39K
- Dijana MusicGlendale$14K
- Christopher HansenGlendale$13K
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Alyssa BoschenPhoenix$86K
- Christopher BeroScottsdale$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.